 Britain
approves Moderna's COVID-19 vaccine for use
Send a link to a friend
[January 08, 2021]
LONDON (Reuters) -Britain's medical
regulator on Friday approved Moderna's COVID-19 vaccine for use, the
health ministry said, adding that it had agreed to purchase an
additional 10 million doses of the shot as it eyed a spring rollout of
the shot.
|
|
 Three COVID-19 vaccines have now been approved for use in Britain,
with Pfizer/BioNTech's shot and one developed by Oxford University
and AstraZeneca already being rolled out.
Britain now has 17 million doses of Moderna's vaccine on order, and
supplies will begin to be delivered to the UK from spring once
Moderna expands its production capability.
"We have already vaccinated nearly 1.5 million people across the UK
and Moderna’s vaccine will allow us to accelerate our vaccination
programme even further once doses become available from the spring,"
health minister Matt Hancock said.
[to top of second column] |
 Moderna's vaccine was 94%
effective in preventing disease in late stage
clinical trials, and it has already been
approved for use in the United States, Canada
and the European Union.
(Reporting by Alistair Smout; editing by Guy
Faulconbridge)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
